RETN and obesity disorder: Its circulating levels in animal models of obesity and diabetes are increased, suggesting a deregulation of resistin production in these conditions, and both in vivo and in vitro studies have shown that resistin exerts an inhibitory effect on glucose uptake in murine adipocytes and muscle cells [158,159,160].